Ocrelizumab May Double Serious Infection Risk in MS

(MedPage Today) — Multiple sclerosis (MS) patients treated with ocrelizumab (Ocrevus) had a higher risk of infections over time than other MS patients, a real-world cohort study showed.
The risk for serious infection was higher (OR 1.98, 95…